Secretory otitis media, oral decongestant and antihistamine. 1981

O K Haugeto, and K E Schrøder, and I W Mair

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D010034 Otitis Media with Effusion Inflammation of the middle ear with a clear pale yellow-colored transudate. Middle Ear Effusion,Otitis Media, Secretory,Otitis Media, Serous,Ear Effusion, Middle,Ear Effusions, Middle,Effusion, Middle Ear,Effusions, Middle Ear,Middle Ear Effusions,Secretory Otitis Media,Serous Otitis Media
D010665 Phenylpropanolamine A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. Norephedrine,Dexatrim,Phenylpropanolamine Hydrochloride,Prolamine,Propagest,Triaminic DM,Hydrochloride, Phenylpropanolamine
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D001977 Brompheniramine Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria. p-Bromdylamine,para-Bromdylamine,Brompheniramine Maleate,Brompheniramine Maleate (1:1),Chlorphed,Dimetane,Dimetane-Ten,Dimetapp Allergy,Oraminic-2,Dimetane Ten,Maleate, Brompheniramine,Oraminic 2,p Bromdylamine,para Bromdylamine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

O K Haugeto, and K E Schrøder, and I W Mair
February 1983, The Journal of pediatrics,
O K Haugeto, and K E Schrøder, and I W Mair
June 1983, The New England journal of medicine,
O K Haugeto, and K E Schrøder, and I W Mair
October 1990, Canadian family physician Medecin de famille canadien,
O K Haugeto, and K E Schrøder, and I W Mair
March 1979, Pediatrics,
O K Haugeto, and K E Schrøder, and I W Mair
November 1988, Canadian family physician Medecin de famille canadien,
O K Haugeto, and K E Schrøder, and I W Mair
December 1964, Western medicine; the medical journal of the west,
O K Haugeto, and K E Schrøder, and I W Mair
September 1983, British medical journal (Clinical research ed.),
O K Haugeto, and K E Schrøder, and I W Mair
March 1987, The Journal of family practice,
O K Haugeto, and K E Schrøder, and I W Mair
September 1979, International journal of pediatric otorhinolaryngology,
Copied contents to your clipboard!